PVT1 and asthma: Subsequent targeting studies in ASMCs from patients with severe asthma showed that inhibition of lncRNA PVT1 with siRNAs increases FCS plus TGF-β–induced cellular proliferation through targeting of the transcription factor c-MYC, revealing its importance in controlling both proliferation and IL-6 release in ASMCs (Austin et al., 2017).